Katarzyna Agopsowicz

Katarzyna Agopsowicz

Auto-generated profile, based on publicly available information

Katarzyna Agopsowicz

Https://orcid.org

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
MPMichalina Piwowar
Michalina Piwowar
KAKatarzyna Agopsowicz
Katarzyna Agopsowicz
KBKatarzyna Blicharz
Katarzyna Blicharz
PZPiotr Zdziebło
Piotr Zdziebło
MSMaria Sitko
Maria Sitko
IBIgor Biernacki
Igor Biernacki
Energy drinks are products that have gained popularity in recent years among people seeking a quick energy boost. The ingredients they contain are intended to reduce the feeling of fatigue, improve the body's performance and concentration. The consumption of energy drinks raises controversy due to their potential negative impact on health, particularly on the cardiovascular system. Thanks to the increased interest of scientists in this topic, many reports of cardiovascular events related to the consumption of energy drinks have been created. This article discusses the composition of energy drinks their association with arrhythmias, hypertension, myocardial infarction, and coronary vasospasm., as well as examples of adverse events that occurred after their consumption.While further research is necessary to fully understand the long-term cardiovascular outcomes, this review highlights the importance of public awareness and regulatory measures to mitigate potential health risks associated with energy drink use.

8 September 2025 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
PMPiotr Adam Mikołajczyk
Piotr Adam Mikołajczyk
BBBarbara Buras
Barbara Buras
KAKatarzyna Agopsowicz
Katarzyna Agopsowicz
ZSZofia Klara Stefanik
Zofia Klara Stefanik
JSJulia Stawińska-Dudek
Julia Stawińska-Dudek
ABAlicja Baranowska
Alicja Baranowska
Introduction and objective: Vitamin D is essential for overall health, and particularly of the musculoskeletal system, including teeth. Its deficiency is linked to many oral health issues, such as caries susceptibility, impaired odontogenesis, delayed teeth eruption, implant failure and...

11 June 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MBMartyna Biernacka
Martyna Biernacka
ABAnna Bieniasz
Anna Bieniasz
KAKatarzyna Agopsowicz
Katarzyna Agopsowicz
KBKatarzyna Blicharz
Katarzyna Blicharz
IBIgor Biernacki
Igor Biernacki
MPMichalina Piwowar
Michalina Piwowar
Fibromyalgia is a complex and chronic pain syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, hypersensitivity to stimuli, and frequently co-occurring psychological symptoms such as depression and anxiety. Although conventional treatments remain essential, their limited effectiveness combined with the multifaceted nature of fibromyalgia, often leads patients to explore complementary approaches and encourages a holistic management strategy for the disease. This review includes studies from the last 15 years, sourced from PubMed database, that focus on the role of meditation - particularly mindfulness-based practices, as a non-pharmacological intervention in the management of fibromyalgia. A growing body of evidence suggests that techniques incorporating meditation, such as mindfulness, Qigong, yoga, and conscious breathing can reduce pain intensity, improve sleep quality, and alleviate psychological distress. Meditation may also enhance emotional resilience and support self-regulation, offering patients a sense of agency in coping with chronic symptoms. Importantly, some studies indicate that mindfulness-based interventions are not only clinically beneficial but also cost-effective, by reducing reliance on healthcare resources. While methodological limitations remain present in much of the research, meditation-based therapies emerge as a promising and accessible complement to conventional fibromyalgia treatments, supporting a more holistic and patient-centered model of care.

5 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KAKatarzyna Agopsowicz
Katarzyna Agopsowicz
KBKatarzyna Blicharz
Katarzyna Blicharz
ABAnna Bieniasz
Anna Bieniasz
MPMichalina Piwowar
Michalina Piwowar
AZAnna Zdziebło
Anna Zdziebło
IBIgor Biernacki
Igor Biernacki
The role of vitamin D in preserving muscle function and bone health in postmenopausal women has gained significant scientific interest. Menopause, characterized by a decline in estrogen levels, heightens the risk of osteoporosis and sarcopenia, significantly affecting mobility and quality of life. It is also associated with various physiological changes, such as hot flashes, mood disturbances, sleep irregularities, and an increased likelihood of musculoskeletal decline. (Sharma M et al. 2024; Santoro N et al. 2021; Santoro N et al. 2015). Vitamin D plays a pivotal role in calcium homeostasis, bone remodeling, and muscle function. However, its deficiency is widespread among postmenopausal women and has been linked to decreased bone mineral density, heightened fracture susceptibility, and diminished muscle performance. Although vitamin D supplementation is frequently recommended to mitigate these effects, its efficacy in enhancing musculoskeletal health remains a subject of debate. Recent studies have identified vitamin D receptors (VDR) in human muscle tissue, supporting the hypothesis that vitamin D contributes to muscle cell proliferation, differentiation, and function (Iolascon G et al. 2018). Despite these findings, inconsistencies in research outcomes and gaps in understanding the physiological mechanisms of vitamin D’s action highlight the need for further investigation into how different levels of vitamin D influence musculoskeletal health and overall well-being in menopausal women. This review evaluates evidence on vitamin D’s impact on muscle strength, bone density, and fracture risk in postmenopausal women, focusing on its therapeutic potential.

5 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ABAnna Bieniasz
Anna Bieniasz
AZAnna Zdziebło
Anna Zdziebło
KZKatarzyna Zdziebło
Katarzyna Zdziebło
MSMaria Sitko
Maria Sitko
DSDominika Stolarczyk
Dominika Stolarczyk
MBMartyna Biernacka
Martyna Biernacka
Cystic fibrosis (CF) is one of the most widespread genetic disorders worldwide. The disease is caused by a mutation in the CFTR gene, which impairs the transport of chloride and bicarbonate ions across the cell membrane, leading to dysfunction of multiple organ systems - primarily the respiratory and digestive systems. Over the years, the availability of new pharmacological therapies has significantly improved both the quality and length of life in CF patients. Nevertheless, non-pharmacological treatment remains an integral component of the overall therapeutic approach. Physical activity is recommended not only for the general population but is also increasingly recognized for its beneficial effects in patients with various chronic diseases. The multifaceted impact of exercise on the human body is a frequent subject of scientific investigation. With the increasing life expectancy of individuals with CF, there is a growing risk of developing comorbidities, including lifestyle-related diseases, which may lead to overlapping symptoms. In modern clinical practice, cystic fibrosis is not always the direct cause of death in these patients. Therefore, it is crucial to adopt a holistic approach to the health of CF patients. Numerous studies have investigated the role of physical activity and exercise in cystic fibrosis, highlighting both the benefits and limitations imposed by the disease. Positive outcomes have been reported, including improved physical performance parameters, which contribute to enhanced quality of life and overall functioning. Additionally, exercise has been associated with improved mental health. A key conclusion emerging from these studies is the importance of personalized treatment plans that consider disease severity, physical and economic conditions, and the need to support patient motivation and adherence to exercise regimens.

27 June 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KAKatarzyna Agopsowicz
Katarzyna Agopsowicz
KBKatarzyna Blicharz
Katarzyna Blicharz
MPMichalina Piwowar
Michalina Piwowar
ABAleksandra Bąk
Aleksandra Bąk
AZAnna Zdziebło
Anna Zdziebło
PMPiotr Mikołajczyk
Piotr Mikołajczyk
Artificial sweeteners (AS), commonly used as sugar substitutes, have gained popularity due to their low caloric value and perceived benefits in supporting glycemic control. Initially introduced to help reduce sugar consumption, their actual impact on glucose metabolism in humans remains unclear. This review explores the current scientific evidence on the relationship between artificial sweeteners and glycemic control, with a focus on individuals with or at risk of metabolic disorders such as type 2 diabetes and insulin resistance. Key mechanisms are discussed, including the influence of artificial sweeteners on insulin response, sweet taste receptor activity, and gut microbiota composition. Human studies have produced mixed results: while some suggest potential benefits in terms of maintaining glucose balance, others indicate possible disturbances in glycemic regulation. Given the widespread consumption of these compounds, especially among people aiming to manage body weight or blood sugar levels, it is essential to better understand their long-term metabolic effects. This review underscores the importance of further well-designed clinical studies to clarify the role of artificial sweeteners in glycemic control and metabolic health.